MedPath

LARS in Ovarian Cancer Patients

Completed
Conditions
Low Anterior Resection Syndrome
Interventions
Other: low anterior resection syndrome evaluation
Registration Number
NCT04279080
Lead Sponsor
Medical University of Vienna
Brief Summary

Background:

Low anterior resection syndrome (LARS) is a common functional disorder after low anterior resection impacting quality of life. Data on LARS derives nearly exclusively from rectal cancer studies. Therefore, the study was designed to assess LARS in advanced epithelial ovarian cancer (EOC) patients, who underwent rectal resection and to compare it with a female rectal cancer cohort.

Methods:

A cross-sectional multi-centre analysis was performed for female patients suffering from either rectal or EOC who received a low anterior resection as part of their therapy regimen. None of the patients received pre- or postoperative radiotherapy. LARS was defined by using the validated LARS score and its severity was divided into "no", "minor" and "major LARS".

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
125
Inclusion Criteria
  • low anterior resection because of ovarian or rectal cancer
Read More
Exclusion Criteria
  • neoadjuvant or adjuvant radiotherapy
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
1low anterior resection syndrome evaluationrectal cancer patients
2low anterior resection syndrome evaluationovarian cancer patients
Primary Outcome Measures
NameTimeMethod
functional bowel outcome after low anterior resection1 year

low anterior resection syndrome score, questionnaire via telephone call or personal contact

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath